Cytokinetics Inc
NASDAQ:CYTK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cytokinetics Inc
NASDAQ:CYTK
|
US |
|
Medibank Private Ltd
ASX:MPL
|
AU |
|
P
|
Philip Morris CR as
PSE:TABAK
|
CZ |
|
Avenir Telecom SA
PAR:AVT
|
FR |
|
R
|
Reata Pharmaceuticals Inc
F:2R3
|
US |
|
Park Ha Biological Technology Co Ltd
NASDAQ:PHH
|
CN |
|
J
|
JMT Network Services PCL
SET:JMT
|
TH |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
Getaround Inc
OTC:GETR
|
US |
|
Kuros Biosciences AG
SIX:KURN
|
CH |
Intrinsic Value
The
intrinsic value for
Cytokinetics Inc (CYTK)
under the Base Case is
hidden
USD.
Compared with the current market price of 66.73 USD, the stock appears
hidden
.
CYTK looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CYTK usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cytokinetics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Cytokinetics Inc
Earnings Waterfall
Cytokinetics Inc
The
intrinsic value for
Cytokinetics Inc (CYTK)
under the Base Case is
hidden
USD.
Compared with the current market price of 66.73 USD, the stock appears hidden .